Filana Therapeutics FLNA
NASDAQ FLNA
$0.95 +0.01 (+1.30%)
As of: Aug 21, 2026 · 2:52 PM EDT

Filana Therapeutics (FLNA) FCF Margin Growth (3y) (2013)

Filana Therapeutics (FLNA) FCF Margin Growth (3y) (2013) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.60 Bn 130.75 Bn 2.84 Bn -1,272.00
2 Regeneron Pharmaceuticals 85.93 Bn 77.93 Bn 3.93 Bn -2,228.00
3 Argenx Se 65.06 Bn 59.88 Bn 1.37 Bn -
4 Moderna 56.22 Bn 51.08 Bn 52.00 Mn -5,426.00
5 BeOne Medicines 42.03 Bn 36.93 Bn 1.53 Bn 9,545.00
6 Alnylam Pharmaceuticals 31.65 Bn 28.34 Bn 992.69 Mn 4,612.00
7 BioNTech SE 27.70 Bn 9.31 Bn 668.28 Mn 1,850.00
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 14,060.00
9 Royalty Pharma 27.31 Bn 26.48 Bn - -3,088.00
10 Filana Therapeutics 46.11 Mn 46.11 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2013 3,853.00
Sep 30, 2013 -21,138.00